Nusinersen improves walking distance and reduces fatigue in later‐onset spinal muscular atrophy

INTRODUCTION: Ambulatory individuals with spinal muscular atrophy (SMA) experience muscle weakness, gait impairments, and fatigue that affect their walking ability. Improvements have been observed in motor function in children treated with nusinersen, but its impact on fatigue has not been studied....

Descripción completa

Detalles Bibliográficos
Autores principales: Montes, Jacqueline, Dunaway Young, Sally, Mazzone, Elena S., Pasternak, Amy, Glanzman, Allan M., Finkel, Richard S., Darras, Basil T., Muntoni, Francesco, Mercuri, Eugenio, De Vivo, Darryl C., Bishop, Kathie M., Schneider, Eugene, Bennett, C. Frank, Foster, Richard, Farwell, Wildon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Clinical Research Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771553/
https://www.ncbi.nlm.nih.gov/pubmed/31298747
http://dx.doi.org/10.1002/mus.26633

Ejemplares similares

Ejemplares similares